Archive for the ‘Research’ Category
by Tania Bubela Increasingly, commercialization is a key requirement for securing project funding and support for scientific research. The field of stem cell research is no exception. But does this emphasis on commercialization, which necessarily involves issues of ownership and secrecy, come at the expense of another largely-encouraged element of scientific research, namely academic collaboration?…Read more
In the body, cartilage has minimal potential to heal itself once damaged, as the tissue is not naturally exposed to a blood supply, and is then prevented from benefiting from the body’s immune response and wound healing capabilities. By using a tissue engineering approach, researchers hope to develop replacement cartilage that can be transplanted into…Read more
Earlier this month, the New Scientist shook up the stem cell community, putting forth the idea that publication speed, frequency, and journal quality might be skewed by where you’re from and who you know rather than the quality of your data. The article, entitled “Paper trail: Inside the stem cell wars” was inspired by an…Read more
And the last word (or words) goes to Fabio Rossi of the University of British Columbia. So ends a great conference!
Our couch is just too inviting… more comments on ISSCR 2010 from Mike Kallos of the University of Calgary and Feodor Price of the Ottawa Hospital Research Institute.
More ISSCR meeting insights from James Ellis of Toronto’s Hospital for Sick Children and Michael Rudnicki, Scientific Director of the Stem Cell Network.
More thoughts on the ISSCR conference in San Francisco from the attendees.
We’re a the ISSCR meeting in San Francisco inviting folks to stop by the Stem Cell Network booth (number 509), sit on our comfy couch and talk about what they’ve enjoyed the most at the 2010 ISSCR annual meeting. Featured here are Bernard Thébaud of the University of Alberta and Rebecca Skinner of the Australian Stem…Read more
Simple diagram that shows the development of different blood cells from hematopoietic stem cell to mature cells. From Wikipedia. All blood cells arise from the common hematopoietic stem cell and are classified into two lineages: lymphoid cells (B-, T- and Natural Killer [NK] cells) which play an important role in adaptive and innate immune response,…Read more
When using stem cells for regenerative therapies, there are a few approaches that can be taken. Donor cells have issues with matching and immune rejection. Autologous stem cells transplants skirt rejection issues, but both strategies still face challenges associated with the ex vivo expansion of cells, such as culture consistency and the need for better…Read more